Rainbow BioSciences, LLC: n3D Technology Advances Cell Research
11/7/2012 9:23:25 AM
NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that 3D cell culturing technology developed by its joint venture partner Nano3D BioSciences (n3D) was recently used in a breakthrough study using stem cells. Dr. Mikhail Kolonin, an associate professor at the University of Texas Health Science Center at Houston, and Dr. Glauco Souza of n3D authored a study that demonstrates how effective 3D cell culturing by magnetic levitation is in generating white adipose tissue organoids, or adiposphere. In a significant breakthrough, these 3D structures presented vascular-like structures when pre-adpocyte stem cells were co-cultured with endothelial cells.